Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaakko Kangas

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical Science (London, England : 1979)|December 13, 2016
Angiopoietin-Tie signalling in the cardiovascular and lymphatic systemsLauri Eklund, Jaakko Kangas, Pipsa Saharinen
Basic & Clinical Pharmacology & Toxicology|April 19, 2018
Development of Molecular Therapies for Venous MalformationsJaakko Kangas, Marjut Nätynki, Lauri Eklund
American Journal of Human Genetics|December 7, 2015
Somatic Activating PIK3CA Mutations Cause Venous MalformationNisha Limaye, Jaakko Kangas, Antonella Mendola, et al.
Human Molecular Genetics|August 31, 2015
Common and specific effects of TIE2 mutations causing venous malformationsMarjut Nätynki, Jaakko Kangas, Ilkka Miinalainen, et al.
Human Molecular Genetics|May 2, 2013
Venous malformation-causative TIE2 mutations mediate an AKT-dependent decrease in PDGFBMelanie Uebelhoer, Marjut Nätynki, Jaakko Kangas, et al.
Journal of Cell Science|February 24, 2012
Ligand oligomerization state controls Tie2 receptor trafficking and angiopoietin-2-specific responsesRiikka Pietilä, Marjut Nätynki, Tuomas Tammela, et al.
The Journal of Investigative Dermatology|August 14, 2016
Blue Rubber Bleb Nevus (BRBN) Syndrome Is Caused by Somatic TEK (TIE2) MutationsJulie Soblet, Jaakko Kangas, Marjut Nätynki, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Science (London, England : 1979)|December 13, 2016
Angiopoietin-Tie signalling in the cardiovascular and lymphatic systemsLauri Eklund, Jaakko Kangas, Pipsa Saharinen
Basic & Clinical Pharmacology & Toxicology|April 19, 2018
Development of Molecular Therapies for Venous MalformationsJaakko Kangas, Marjut Nätynki, Lauri Eklund
American Journal of Human Genetics|December 7, 2015
Somatic Activating PIK3CA Mutations Cause Venous MalformationNisha Limaye, Jaakko Kangas, Antonella Mendola, et al.
Human Molecular Genetics|August 31, 2015
Common and specific effects of TIE2 mutations causing venous malformationsMarjut Nätynki, Jaakko Kangas, Ilkka Miinalainen, et al.
Human Molecular Genetics|May 2, 2013
Venous malformation-causative TIE2 mutations mediate an AKT-dependent decrease in PDGFBMelanie Uebelhoer, Marjut Nätynki, Jaakko Kangas, et al.
Journal of Cell Science|February 24, 2012
Ligand oligomerization state controls Tie2 receptor trafficking and angiopoietin-2-specific responsesRiikka Pietilä, Marjut Nätynki, Tuomas Tammela, et al.
The Journal of Investigative Dermatology|August 14, 2016
Blue Rubber Bleb Nevus (BRBN) Syndrome Is Caused by Somatic TEK (TIE2) MutationsJulie Soblet, Jaakko Kangas, Marjut Nätynki, et al.
Pageof 1